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Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most important nosocomial
pathogens and is also emerging in Turkish hospitals. The aim of this study was to determine the antimicrobial
susceptibility profiles of MRSA isolated from Turkish hospitals.
Materials and methods: A total of 397 MRSA strains isolated from 12 hospitals in Turkey were included to present
study. Antimicrobial susceptibilities were tested using agar dilution method. Presence of ermA, ermB, ermC, msrA,
tetM, tetK, linA and aac-aph genes were studied by PCR.
Results: All strains were susceptible to vancomycin and linezolid. The susceptibility rates for fusidic acid, lincomycin,
erythromycin, tetracyclin, gentamycin, kanamycin, and, ciprofloxacin were 91.9%, 41.1%, 27.2%, 11.8%, 8.5%, 8.3%
and 6.8%, respectively. Lincomycin inactivation was positive for 3 isolates. Of 225 erythromycin resistant isolates 48
had ermA, 20 had ermC, and 128 had ermA-C. PCR was negative for 15 strains. Of 3 isolates with lincomycin
inactivation one had linA and msrA. Of 358 gentamycin resistant isolates 334 had aac-aph and 24 were negatives.
Among 350 tetracyclin resistant isolates 314 had tetM. Of 36 tetM negative isolates 10 had tetK.
Conclusion: MRSA isolates from Turkish hospitals were multiresistant to antimicrobials. Quinolone and gentamycin
resistance levels were high and macrolide and lincosamide resistance were relatively low. Susceptibility rates for
fusidic asid were high. Linezolide and vancomycin resistance are not emerged. The most common resistance genes
were ermA, tetM and aac-aph. Evolution of antimicrobial susceptibilities and resistance genes profiles of MRSA
isolates should be surveyed at regional and national level for accurate treatment of patients and to control
dissemination of resistance genes.
Keywords: Staphylococci, MRSA, Antimicrobial susceptibility, Resistance mechanisms, PCRIntroduction
Staphylococci are important infection agents that cause
hospital and community acquired infections. These
bacteria have ability to adapt themselves to difficult
conditions and successful clones have capacity of epidemic
and pandemic dissemination [1]. Increasing resistance
problem in staphylococci became an important public* Correspondence: bbozdogan@gmail.com
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unless otherwise stated.health problem. In 1944 when penicillin became available
for use the susceptibility rate of Staphylococcus aureus
to penicillin was >94% which became <5% recently [2].
Methicillin resistance appeared and started to disseminate
from 1980 and became one of the major problem in
hospital infections. Methicillin resistance is due to
acquisition of a transpeptidase, PBP2a, involved in cell wall
synthesis that has low affinity for beta lactam antibiotics
which rends bacteria resistant to all beta lactam antibiotics.
Treatment of infections due to methicillin resistant S.
aureus (MRSA) causes problems due to restricted number
of choices [1]. Especially from 2003, when vancomycintd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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treatment possibilities for these bacteria [3]. In addition
emergence and dissemination of community MRSA
isolates forced to evaluate empiric treatment options
in consideration with changing resistance profiles of these
bacteria. MRSA strains do not affect only human but also
infect farm animals and pets [4]. Although development
of new antibiotics reduced dramatically recently, some
antibiotics like daptomycin, linezolid and tigecyclin could
be commercialized lately [1].
In the present study susceptibilities of 397 MRSA
isolated from 12 centers in Turkey to linezolid, fusidic
acid, kanamycin, gentamycin, erythromycin, lincomycin,
tetracyclin, vancomycin and ciprofloxacin were tested by
agar dilution method and presence known resistance
genes were verified by PCR using specific primers.
Materials and methods
A total of 12 centers from 11 cities participated to the
present study and sent MRSA isolates to Aydın where
susceptibility testing and molecular studies were done at
ADU BILTEM Epidemiology Unit. Methicillin resistance
was confirmed by cefoxitin disc method. A total of 397
MRSA isolates were collected from hospitalized patients
between 2006–2008, from Aydın (15 isolates), Izmir (2
centres 17 and 22 isolates), Afyon (32), Manisa (23), Van
(42), Trabzon (54), Samsun (51), Ankara (31), Konya (28),
Istanbul (55), and Edirne (36).
Determination of antimicrobial susceptibilities
Agar dilution method
Antibiotics tested were linezolid, fusidic acid, kanamycin,
gentamycin, erythromycin, lincomycin, tetracyclin, vanco-
mycin and ciprofloxacin. Erythromycin and fusidic acid
were from Koçak Farma (Tekirdağ, Türkiye), kanamycin,
tetracyclin and vancomycin were purchased from Sigma,
and commercial injectable preparations were used for the
remaining antimicrobials. Agar dilution method was used as
described previously [5]. Shortly plates were prepared
with serial dilution from 64 or 128 mg/L antibiotic
concentrations. Inoculum with 5X104 bacteria was placed
onto agar using multipoint inoculator. After 16–20 h
incubation at 37°C the lowest concentration that inhibits
bacterial growth was accepted as MIC. Reference strain S.
aureus RN4220 was included to each run.
Gots test
All lincomycin resistant isolates were tested by Gots’ test
for presence of resistance by antibiotic inactivation.
For this purpose to 19 ml agar at 50-60°C 19 ml BHI
(Brain Heart infusion) agar 0,5 mg/L clindamycin and
1 ml overnight broth of Micrococcus luteus ATCC9341
were added, mixed and poured to petri dish and left for
solidification. The MRSA isolates were inoculated as smallround onto agar. On one plate approximately 20 MRSA
isolates were inoculated. After 24 h incubation at 37°C
plates were left 24 h at room temperature. Growth of
indicator bacteria in the round of tested bacteria was
accepted as positive which showed presence of resistance
mechanism by inactivation [6].
Determination of resistance mechanisms
DNA extraction
DNA extraction was done using Instagen Matrix (BioRad)
as recommended by manufacturer. Shortly 1–2 colonies
were homogenized in 1 ml of distillated water and centri-
fuged at 10000 rpm for 1 minute. Supernatant were dis-
carded and pellet was homogenized with 100 μl of instagen
matrix. After incubation at 55°C during 15–30 min the
mixture was vortexed and incubated at 95°C during 8 min.
Lysate were centrifuged and 2 μl of supernatant were used
as DNA for PCR reactions.
PCR
Erythromycin, lincomycin, gentamycin and tetracyclin
resistant MRSA isolates were tested for the presence of
msrA, ermA, ermB, ermC, linA, linB, aac-aph, tetM and
tetK genes by PCR using specific primers. List of the
primers and PCR conditions are shown in Table 1 [7-11].
Results
Susceptibilities to antibiotics
MICs and resistance was evaluated using CLSI criteria [12].
All 397 MRSA isolates tested were found to be susceptible
to vancomycin and linezolid. Only 8 of 397 MRSA isolates
were susceptible to all antibiotics tested. In Table 2 MIC50
and MIC90 of the isolates are shown for each antibiotic
tested. The number of resistant isolates to erythromycin,
lincomycin, tetracyclin, gentamycin, fusidik acid, ciprofloxa-
cin and kanamycin were 225 (%56.7), 168 (%42.3), 350 (%
88.2), 358 (%90.2), 32 (%8.1), 366 (%92.2), and 363 (%91.4),
respectively (Table 3). Distribution of resistance levels for
the antibiotics for each centre is shown at Table 4.
Resistance mechanisms
Of 225 erythromycin resistant MRSA isolates 48 carried
ermA, 20 carried ermC, 1 carried both ermA and ermB,
1 carried both ermB and ermC, 128 carried both ermA
and ermC, 2 carried ermA, ermB and ermC, 2 carried
msrA, 2 carried msrA and ermA, 1 had msrA and ermB,
4 had msrA, ermA and ermC, 1 had msrA and ermC
genes. A total of 15 isolates were negatives for all
erythromycin resistance genes tested. Among MRSA
isolates 64 were intermediate resistant to erythromycin.
Of these isolates 36 were positive for ermA, 1 isolate had
both ermA and ermC, and 1 isolate was positive for
msrA. All remaining 26 isolates were negatives for the
genes tested. Among 168 lincomycin resistant isolates 9
Table 1 Primers and PCR conditions used to amplify resistance genes
Resistance genes Primers PCR conditions References
ermA F 5′TCT AAA AAG CAT GTA AAA GAA3′ Pre cycle 93°C 3 min, [7] Sutcliffe 1996
R 5′CTT CGA TAG TTT ATT AAT ATT AGT3′ 35 cycles: 93°C 60 s, 52°C 60 s, 72°C 60 s
ermB F 5′GAA AAG GTA CTC AAC CAA ATA3′ Last cycle 72°C 5 min
R 5′AGT AAC GGT ACT TAA ATT GTT TAC3′
ermC F 5′GCT AAT ATT GTT TAA ATC GTC AAT TCC3′
R 5′GGA TCA GGA AAA GGA CAT TTT AC3′
msrA F 5′GCA AAT GGT GTA GGT AAG ACA ACT3′ Pre cycle 93°C 3 min, [7] Sutcliffe 1996
R 5′ATC ATG TGA TGT AAA CAA AAT3′ 35 cycles: 93°C 30 s, 52°C 30 s, 72°C 60 s
Last cycles 72°C 10 min
linA F 5′GTA TTA ACT GGA AAA CAG CAA AG3′ Pre cycle 5 dk 94°C [10] Lina 1999
R 5′GAG CTT CTT TTG AAA TAC ATG G3′ 35 cycles 45 s 94°C, 45 s 54°C,1 min at 72°C
linB F 5′CCTACCTATTGTTTGTGGAA 3′ Last cycle 5 min at 72°C [11] Bozdogan 1999
R 5′ATAACGTTACTCTCCTATTC 3′
tetM F 5′GTG GAC AAA GGT ACA ACG AG3′ Pre cycle 93oC’de 5 dk [9] Warsa 1996
R 5′CGG TAA AGT TCG TCA CAC AC3′ 35 cycles 93°C 60 s, 52°C 60 s, 72°C 60 s
tetK F 5′CAG CAG ATC CTA CTC CTT3′ Last cycle 10 min at 72°C
R 5′TCG ATA GGA ACA GCA GTA3′
aac-aph F 5′GAG CAA TAA GGG CAT ACC AAA AAT C3′ Pre cycle 94C’de 5 dk, [8] Kao 2000
R 5′CCG TGC ATT TGT CTT AAA AAA CTG G3′ 35 cycles 94°C 30 s, 50°C 30 s, 72°C 30 s
Last cycle 7 min at 72°C
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had both ermB and ermC, 124 had both ermA and
ermC, 4 had msrA, ermA and ermC, 2 had ermA, ermB
and ermC, 1 had linA and msrA, 1 had ermC and msrA
genes found and 8 isolates were negative by PCR for the
genes tested. All lincomycin resistant isolates were
tested for clindamycin inactivation by Gots’ test and 3
isolates were found to be positive for inactivation. Of
these 3 isolates one carried linA gene responsible for
lincosamide inactivation and also msrA gene, but
remaining 2 isolates were negatives for both linA and
linB genes.Table 2 MIC50, and MIC90 values for antibiotics tested for
MRSA isolates









Gentamycin 64 128Among macrolide resistant isolates the most frequently
encountered gene was ermA (185 isolates) folloved by ermC
(157 isolates), msrA (10 isolates) and ermB (9 isolates).
A total of 358 isolates were resistant to gentamycin
and 334 of these isolates were positive for aac-aph gene
and remaining 24 isolates were negative for this gene.
It was found that 350 of 397 isolates were resistant to
tetracyclin. Of these 350 isolates 314 carried tetM gene
and 36 did not carry this gene. Among tetM negative 36
isolates 10 had tetK gene and remaining 26 isolates were
negative both tetM and tetK. Distribution of resistance
genes among resistant isolates are shown in Table 5.
Among macrolide resistance isolates the most common
gene combination was ermA–ermC. Among tetracyclin and
gentamycin resistant isolates the most common resistant
genes were tetM and aac-aph, respectively.
Discussion
Antibiotic resistance became an important public health
problem in Turkey as it is in whole world. Restriction of
beta lactam use in MRSA isolates required use of other
types of antibiotics for the treatment of infections due to
MRSA isolates so survey of susceptibilities of MRSA
isolates for antibiotics other than beta lactams became
very important.
Our study is the largest study done in Turkey
which evaluates both phenotypic and genotypic aspect
Table 3 Prevalence of resistance rates of 397 MRSA isolates







Erythromycin 225 (56.7) 64 (16.1) 108 (27.2)
Lincomycin 168 (42.3) 66 (16.6) 163 (41.1)
Tetracyclin 350 (88.2) 0 47 (11.8)
Ciprofloxacin 366 (92.2) 4 (1) 27 (6,8)
Kanamycin 363(91.4) 1 (0.3) 33 (8.3)
Gentamycin 358 (90.2) 5 (1.3) 34 (8.5)
Fusidic Acid 32 (8.1) 0 365 (91.9)
Linezolid 0 0 397 (100)
Vancomycin 0 0 397 (100)
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done in Harran University, Urfa at 2004 indicated that
erythromycin, clindamycin, gentamycin and ciprofloxacin
resistant among MRSA isolates 63%, 50%, 81% and 25%,
respectively [13]. Other study done at Manisa, at 2007
evaluated resistance of MRSA isolated from 1998 to 2002
[14]. It was shown that erythromycin resistance decreased
from 59.5% to 51%, clindamycin resistance increased from
28.4% to 41.5%, tetracyclin resistance increased from
57.6% to 88%, and gentamycin resistance from 28.4% to%
87.5, ciprofloxacin resistance from 34.1% to 92.2%.
Our study confirmed the tendency for increase in the
resistance level of ciprofloxacin, tetracyclin and gentamycin.
Sarıbas et al. investigated macrolide resistance genes among
MRSA isolates and showed that macrolide resistance level
was 29.9% and 86% of the resistant isolates carried ermATable 4 Resistance rates by centre of MRSA isolates
% of resistant isolates
Centre (No of isolates) Tetra** Cipro Line F. A
Aydın (15) 86.6 100 0 0
İzmir (17)A* 94.1 100 0 5.8
İzmir (22)B* 95.4 100 0 9.1
Afyon (23) 91.3 86.9 0 21.7
Manisa (23) 95.6 86.9 0 0
Van (42) 95.2 97.6 0 2.4
Trabzon (54) 88.9 74.1 0 12.9
Samsun (51) 98 94.1 0 7.8
Ankara (31) 100 100 0 0
Konya (28) 92.8 96.4 0 10.7
İstanbul (55) 52.7 96.3 0 3.6
Edirne (36) 88.8 88.8 0 8.3
Toplam (397) 88.2 92.2 0 8.1
*A: Katip Celebi University Bozyaka Hospital, B: Izmir Atatürk State Hospital.
**Tetra, Tetracycline; Cipro, Ciprofloxacin; Line, Linezolid; F. Acid, Fusidic Acid; Vanc
Genta; Gentamycin.gene [15]. Sarıbaş et al. found resistance level lower than
our study and other studies from Turkey however
resistance gene profile was similar with 86% of ermA gene
but in our study more than 50% of ermA positive isolates
also carried ermC gene. Gül et al. evaluated erythromycin
resistance rate among MRSA isolated between 2003–2006
and found resistance rate as 84.9% [16]. Of resistant
isolates 37.7% had ermA 26.6% had ermC and 18.6%
had both ermA and ermC [16]. Aktaş et al. studied 22
erythromycin resistant MRSA isolated in Istanbul and
found thet the most frequent genotype was presence of
both ermA and ermC 40.9(%) followed by ermC (18.2%)
[17]. Ardıç et al. also found among 28 erythromycin resist-
ant MRSA that presence of both ermA and ermC was the
most frequent genotype [18].
In the world among erythromycin resistant MRSA iso-
lates ermA was the most frequent gene in France (57.6%)
[10], Colombia (78.5%) [19] and Malesia (52.8%) [20] but in
Greece which is neighbour of Turkey ermC (96.5%) [21]
found to be the most frequent gene.
In our study the most frequent mechanism of macrolide
resistance among MRSA isolates found to be presence of
methylase. Presence of methylase may confer inducible
lincomycin resistance which should be taken in consider-
ation for treatment design. The dominant genes among
tetracyclin and aminoglycoside resistant isolates were tetM
and aac-aph, respectively.
The dissemination of resistance was also analysed at
regional level. İsolates from Istanbul had lower tetracycline
resistance than other regions. MRSA isolates from Van had
higher macrolide resistance rates than other regions.
Ciprofloxacin resistance rates were very high in all centerscid Vanco Kana Erythro Linco Genta
0 100 80 60 93.3
0 100 52.9 64.7 88.2
0 90.9 72.7 63.6 90.9
0 86.9 21.7 26.1 82.6
0 95.6 69.5 56.5 91.3
0 95.2 4.7 2.4 92.8
0 70.3 52.7 40.7 68.5
0 92.1 45.1 31.3 90.2
0 96.7 58 41.9 80.6
0 96.4 89.3 46.2 92.8
0 96.3 56.3 58.2 96.3
0 88.8 50 41.6 88.8
0 91.4 56.7 42.3 90.2
o, Vancomycin; Kana, Kanamycin, Erythro, Erythromycin; Linco, Lincomycin;




Erythro* Linco Tetra Genta Cipro Line F. Acid Vanco Kana
225 (56.7) 168 (42.3) 350 (88.2) 358 (90.2) 366 (92.2) 0 (0) 32 (8.1) 0 (0) 363 (91.4)
Gene (%) ermA (21.3) ermA (5.4) tetM (90) aac-aph (93) ND** ND ND ND ND
ermB (0) ermB (0) tetK (2.9)
ermC (8.9) ermC (10.1)
ermA-B (0.4) ermA-B (0.6)
ermB-C (0.4) ermB-C (0.6)
ermA-C (56.9) ermA-C (73.8)
ermA-B-C (0.9) ermA-B-C ( 1.2)
msrA (0.9) msrA (0)
msrA,ermA (0.9) msrA,ermA (0)
msrA, ermB (0.4) msrA, ermB (0)
msrA,ermC (0.4) msrA,ermC (0.6)
linA, msrA (0.6)
msrA,ermA-C (1.8) msrA,ermA-C (2.4)
Unknown (6.6) Unknown (4.7) Unknown (7.1) Unknown (7)
*Erythro, Erythromycin; Linco, Lincomycin; Tetra, Tetracycline; Genta, Gentamycin; Cipro, Ciprofloxacin; Line, Linezolid; F. Acid, Fusidic Acid; Vanco, Vancomycin;
Kana, Kanamycin.
**ND; Not Determined.
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rates were in Aydın, Ankara and Izmir with 100%.
Tetracyclin resistance was lowest in Istanbul with
52.7% and highest in Ankara with 100%. Fusidic acid
resistance rates were relatively low. All isolates from
Ankara, Aydın and Manisa were susceptible to fusidic
acid, and highest resistance rate was in Afyon with
21.7%. Erythromycin resistance was lowest at Van
with 4.7% and highest at Konya with 89.3%. At the
same time Konya was the center where the resistance
rate differences were the highest between erythromycin
and lincomycin. Resistance rates were the lowest in Afyon
and Samsun with <50%. Lincomycin resistance rate was
46.2%. Resistance to gentamycin was lowest in Trabzon
with 68.5% and highest in Istanbul with 96.3%.
In our study the most common gentamycin resistance
gene was aac-aph gene (96%). Ardıç et al. studied with
17 gentamycin resistant MRSA isolates from Istanbul at
2006 and found 16 of 17 (94,1%) isolate carried aac-aph
gene [22]. A study from Iran, neighbour state of Turkey,
showed that isolates from Tehran aac-aph gene was
the most common gene among gentamycin resistant
S. aureus (83%) [23]. Tetracyclin resistance gene tetM
was 90% positive among tetracyclin resistant isolates
which were only 49% among resistant isolates from
Malesia [20].
Conclusion
Our study is one of the largest epidemiological study
done in Turkey. These multi-centre data of resistance
level and mechanism of resistance of MRSA isolates willbe important for future surveillance studies to determine
the evolution of resistance levels and mechanisms at
national and regional level. Also our results and follow
up studies may constitute a database for empirical treat-
ment of infections due to MRSA. Our multicentre study
showed that isolates from 12 centres from Turkey had
multiple resistances. Quinolone and gentamycin resistance
found to be very high. Fusidic acid resistance was low and
erythromycin and lincomycin susceptibility found to be
relatively high. This study indicated that resistance to
linezolid and vancomycin resistance is not emerged
among MRSA isolates from Turkish hospitals.
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